- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Neoplasms in New Zealand
Total 16849 results
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
New York Presbyterian Brooklyn Methodist HospitalCompleted
-
Calvary Mater Newcastle, AustraliaAbbottCompleted
-
Weill Medical College of Cornell UniversityVarian Medical SystemsCompletedBreast Cancer | Prostate CancerUnited States
-
TheradexUnknown
-
Nanospectra Biosciences, Inc.CompletedNeoplasms of the ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingProstate Cancer | Prostatic AdenocarcinomaUnited States
-
Sophiris Bio CorpCompletedProstate CancerUnited Kingdom, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Center for Molecular MedicineUnknown
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
AttenuonProstate Cancer Clinical Trials ConsortiumUnknown
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
GP-PharmCompletedProstate CancerUnited States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsCompletedProstate CancerUnited States
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Weill Medical College of Cornell UniversityActive, not recruitingProstate CancerUnited States
-
Alessa Therapeutics Inc.CompletedLower Urinary Tract Symptoms | Prostate AdenocarcinomaUnited States, Australia, New Zealand
-
University of RochesterVarian Medical SystemsRecruitingRecurrent Prostate Cancer After SurgeryUnited States
-
Genentech, Inc.Completed
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
Invitae CorporationCompleted
-
DendreonCompleted
-
Resurge Therapeutics Inc.RecruitingLower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)New Zealand, Australia
-
National Cancer Institute (NCI)CompletedProstate Carcinoma | No Evidence of DiseaseUnited States
-
PfizerCompletedProstate CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Carolina Research Professionals, LLCBayerCompleted
-
Blue Earth DiagnosticsAmerican College of Radiology; Syne Qua Non Limited; IND 2 Results LLCCompletedProstate CancerUnited States
-
Progen PharmaceuticalsAventis Pharmaceuticals; Northern Sydney and Central Coast Area Health ServiceCompleted
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingMetastatic Castration Sensitive Prostate CancerUnited States
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Northwest BiotherapeuticsWithdrawnProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Prostate Cancer | Advanced Solid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
AstraZenecaParexelCompleted
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States, Canada
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Heinrich-Heine University, DuesseldorfUnknown
-
Johns Hopkins UniversityMemorial Sloan Kettering Cancer CenterCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Candel Therapeutics, Inc.Active, not recruitingProstate CancerUnited States, Puerto Rico